Close Menu
  • Home
  • About
  • Trauma Leadership
    • Program Management
    • System Leadership
    • Trauma Registry
    • Prehospital Trauma
    • Trauma Research
    • Trauma Conferences
  • Trauma Care
  • Jobs
    • Post a Job
    • Employer Dashboard
  • Virtual Summit on Trauma Systems
Facebook X (Twitter) Instagram
Trending
  • (Sponsored Workshop) Introducing the Juniper Health Trauma Data Platform
  • Trauma performance improvement dashboards: a concise guide
  • Open-source software helps Level I trauma center meet ACS publishing requirement
  • Wilderness Medicine: How backcountry care shapes trauma bay outcomes
  • Creating realistic corrective action plans that work for your center
  • Post-mortem CT program enables more accurate ISS, provides team closure
  • Michigan Level II loses trauma designation due to documentation shortfalls
  • Nursing honor society offers free disaster prep and response course
Facebook X (Twitter) Instagram
Trauma System News
  • Home
  • About
  • Trauma Leadership
    • Program Management
    • System Leadership
    • Trauma Registry
    • Prehospital Trauma
    • Trauma Research
    • Trauma Conferences
  • Trauma Care
  • Jobs
    • Post a Job
    • Employer Dashboard
  • Virtual Summit on Trauma Systems
Trauma System News
Photo: Tim Samoff

What do patients think about being enrolled in trauma research without informed consent?

0
By Trauma News on February 24, 2015 Research

Clinical trials for time-sensitive emergency therapies often enroll patients under exception from informed consent (EFIC). U.S. regulations require investigators to conduct a pre-trial “community consultation” with representatives from the communities where the investigation will take place. But what do patients themselves think of EFIC trials? A study publishing next month in Critical Care Medicine explores how injured patients view involuntary enrollment in trauma research.

The study was based on interviews with 85 patients (or their surrogates) enrolled in the Progesterone for the Treatment of Traumatic Brain Injury (ProTECT III) trial. ProTECT III took place at 49 trauma centers in the U.S. between 2009 and 2013.

According to the paper, the interviews showed that EFIC enrollment was generally consistent with the preferences of patients or their surrogates:

  • 84% had a positive attitude toward being included in the trial
  • 72% thought that using EFIC enrollment in the ProTECT III trial was acceptable in general
  • 78% thought their personal inclusion in the trial under EFIC was acceptable
  • 80% thought placebo use was acceptable
  • 92% thought randomization was acceptable

“Only two respondents clearly disagreed with both personal and general exception from informed consent enrollment,” according to the paper. However, the results suggest that black Americans take a relatively dim view of EFIC. “Although there were few black respondents (n = 11), they were less accepting of personal exception from informed consent enrollment than white respondents (55% vs 83%; p = 0.0494).”

Consultations underestimate acceptance?
The paper notes that among ProTECT III participants, patient/surrogate acceptance of EFIC was higher than acceptance of community consultation participants.

For comparison, a 2013 study surveyed participants in a community consultation for the Rapid Anticonvulsant Medication Prior to Arrival Trial (RAMPART). According to the survey, 70% of participants said they would agree to take part in the study, and 68% said they would consent to a family member’s participation.

Author

  • Trauma News
    Trauma News

Related Posts

Survey will explore the state of trauma education

Study: Trauma PI should prioritize pneumonia prevention

Advanced prehospital care teams could reduce preventable trauma deaths

Comments are closed.

About Trauma System News

Trauma System News is the only information channel dedicated to trauma center and trauma system leadership and management. Find out more.

SiteLock
Copyright © 2026 Trauma System News

Type above and press Enter to search. Press Esc to cancel.